Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study

Retrospective Study ◽

Growth Factor ◽

Clinical Outcome ◽

Metastatic Breast ◽

Hormone Receptor Status ◽

Breast Cancer Patients ◽

Trastuzumab Therapy ◽

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2268-9 ◽

2013 ◽

Vol 72 (5) ◽

pp. 1023-1029 ◽

Cited By ~ 1

Author(s):

Ji-Won Kim ◽

Jee Hyun Kim ◽

Seock-Ah Im ◽

Kyung-Hun Lee ◽

Jin-Soo Kim ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Breast ◽

Hormone Receptor Status ◽

First Line ◽

Her2 Positive ◽

Epidermal Growth ◽

Taxane Chemotherapy

Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs17-p3-04-03 ◽

2018 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyr020 ◽

2011 ◽

Vol 41 (5) ◽

pp. 593-599 ◽

Cited By ~ 43

Author(s):

H. J. Chang ◽

S.-W. Han ◽

D.-Y. Oh ◽

S.-A. Im ◽

Y. K. Jeon ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hormone Receptor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Status ◽

Abstract PS9-54: Healthcare costs for metastatic breast cancer patients treated with human epidermal growth factor receptor 2 targeted agents

10.1158/1538-7445.sabcs20-ps9-54 ◽

2021 ◽

Author(s):

Reshma Mahtani ◽

Deepa Lalla ◽

Nina Oestreicher ◽

Augustina Ogbonnaya ◽

Vishal Saundankar ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Healthcare Costs ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Targeted Agents ◽

Breast Cancer Patients ◽

Abstract P1-01-15: DETECT V - Detection of the expression of estrogen receptor and human epidermal growth factor receptor 2 on circulating tumor cells from metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p1-01-15 ◽

2017 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

A Schramm ◽

A Polasik ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P2-03-05: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p2-03-05 ◽

2017 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients

Breast Cancer Research ◽

10.1186/bcr1788 ◽

2007 ◽

Vol 9 (6) ◽

Cited By ~ 50

Author(s):

Kristjan S Asgeirsson ◽

Amit Agrawal ◽

Claire Allen ◽

Anthony Hitch ◽

Ian O Ellis ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study

European Journal of Cancer ◽

10.1016/j.ejca.2014.01.010 ◽

2014 ◽

Vol 50 (5) ◽

pp. 885-891 ◽

Cited By ~ 5

Author(s):

J.M. van Rooijen ◽

L. de Munck ◽

J.C. de Graaf ◽

S. Siesling ◽

E.G. de Vries ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Population Based ◽

Breast Cancer Patients ◽

Population Based Study ◽

MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer

Journal of Cellular Biochemistry ◽

10.1002/jcb.27620 ◽

2018 ◽

Vol 120 (3) ◽

pp. 3459-3466 ◽

Cited By ~ 4

Author(s):

Marwa Badr ◽

Hebatallah Said ◽

Manal L. Louka ◽

Hesham A. Elghazaly ◽

Ahmed Gaballah ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Prognostic Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Trastuzumab Therapy ◽